Correction: Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Advancing Beyond Inhibition: Utilizing the DRD2–VEGF-A Feedback Mechanism for Targeted Anti-Angiogenesis Treatment in Oncology

  • By

  • Manas Ranjan Sahu

  • Venu Akkanapally

  • Partha Sarathi Dasgupta

  • Sujit Basu

  • September 2, 2026

Share

Objective:

To correct the funding information in the previously published article regarding the DRD2-VEGF-A feedback loop in cancer treatment.

Approach:
  • Correction: The article corrects the funding statement to accurately reflect the financial support received from the Ohio State University Comprehensive Cancer Center.
Key Findings:
  • The original funding statement incorrectly listed unrelated NIH/NCI and DOD USA grants.
Interpretation:

The correction clarifies the source of financial support for the research.

Conclusion:

The original version of the article has been updated to reflect the correct funding information.

Sources:

Original Source(s)

Related Content